Manon Durand

3PUBLICATIONS
3CO-AUTHORS
AutoimmunityHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 21, 2024
First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma.

Vincent Cabaud Gibouin, Manon Durand, Christophe Boudesco

|May 22, 2024
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.

Manon Durand, Vincent Cabaud Gibouin, Laurence Duplomb

|Feb 11, 2023
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches.

Vincent Cabaud-Gibouin, Manon Durand, Ronan Quéré

Pageof 1